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Gene expression and its regulation can vary substantially across tissue types. In order to generate knowledge about gene expression in
human tissues, the Genotype-Tissue Expression (GTEx) program has collected transcriptome data in a wide variety of tissue types from
post-mortem donors. However, many tissue types are difficult to access and are not collected in every GTEx individual. Furthermore, in
non-GTEx studies, the accessibility of certain tissue types greatly limits the feasibility and scale of studies of multi-tissue expression. In
this work, we developed multi-tissue imputation methods to impute gene expression in uncollected or inaccessible tissues. Via simula-
tion studies, we showed that the proposedmethods outperform existing imputationmethods inmulti-tissue expression imputation and
that incorporating imputed expression data can improve power to detect phenotype-expression correlations. By analyzing data from
nine selected tissue types in the GTEx pilot project, we demonstrated that harnessing expression quantitative trait loci (eQTLs) and tis-
sue-tissue expression-level correlations can aid imputation of transcriptome data from uncollected GTEx tissues. More importantly, we
showed that by using GTEx data as a reference, one can impute expression levels in inaccessible tissues in non-GTEx expression studies.Introduction
Studies of gene expression in peripheral whole blood, skin,
liver, and other tissues have revealed that gene expression
and its regulation depend on cell context.1 The expression
of a given gene can vary substantially across tissue types,
and the genetic variants that regulate gene expression—
expression quantitative trait loci (eQTLs)2,3—can have
eQTL effects that also vary across tissue types.4–7 A careful
examination of gene expression across human tissues and
within target tissues would not only help to answer a wide
range of scientific questions related to transcriptional vari-
ation but also inform other fundamental aspects of biology
and prioritize therapeutic gene targets in the development
of precision medicine.8 The challenge is that many
tissues are not regenerative and are difficult to collect
(hereinafter referred to as ‘‘inaccessible’’ tissues). To date,
most large-scale gene-expression studies have been con-
ducted with RNA extracted from peripheral-blood cells or
their derivatives, such as lymphoblastoid cell lines. The
blood samples are generally heterogeneous and contain a
mixture of different cell types. The expression in the blood
cells might not directly inform the expression and its reg-
ulatory mechanisms in other target cell types from other
tissues.
The NIH Common Fund’s Genotype-Tissue Expression
(GTEx) program has generated rich transcriptome data in
a wide variety of human tissue types, as well as genome
sequencing data from a large number of post-mortem do-
nors, thus allowing researchers to generate knowledge
about gene expression across human tissues and also char-
acterize the regulatory role of genetic variation from both1Department of Public Health Sciences, University of Chicago, Chicago, IL 6063
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2015, GTEx released pilot data including transcriptome
measurements in 44 reference human tissue types and
sequencing data on 175 donors.11 The GTEx project pro-
vides a unique opportunity to systematically evaluate the
relationships among transcriptomes of different tissues
and inform the design of future studies of multi-tissue
gene expression.
One major challenge of conducting similar types of ana-
lyses in studies beyond GTEx is tissue accessibility. Despite
the importance of obtaining specific target tissues from
additional cohorts of interest, it might be difficult to
collect multi-tissue expression data in many studies. For
example, the collection of inaccessible tissues from living
study participants is neither possible nor ethical, certain
samples in some existing expression studies might not be
available for additional data collection, or certain samples
might have only limited tissue biopsies available, etc. In
those cases, it would be desirable if available information
on the target samples and the rich resources in GTEx could
be harnessed for accurate imputation of the expression
data in the uncollected or inaccessible tissues. With
multi-tissue imputation, we are able to reanalyze and leve-
rage existing single-tissue expression data or design future
multi-tissue expression studies with limited resources.
Compared with single-tissue expression data, multi-tissue
expression data provide a more comprehensive and sys-
tematic view of the underlying biological mechanisms.
Moreover, the expression levels of a gene in functionally
related tissues often show coordinated expression patterns,
reflecting shared developmental and genetic factors. By
jointly analyzing expression data from multiple tissue7, USA; 2Division of GeneticMedicine, Department ofMedicine, Vanderbilt
demic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, the
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Figure 1. Illustrations of Two Imputation Scenarios
In both scenarios, one can apply the proposed methods to impute
the expression in the uncollected or inaccessible tissues of interest.
Each row is one individual, and each column is one tissue type.
The collected and measured tissues are shown in black, and the
uncollected or inaccessible ones are in white. The tissues with
question marks are the ones of interest.
(A) Expression in the uncollected GTEx tissues (with question
marks) was imputed on the basis of expression in the collected
GTEx tissues.
(B) Expression in the uncollected tissues (with question marks),
including inaccessible tissue types, was imputed on the basis of
collected tissues in a new expression study. GTEx was used as a
reference.types, one can enhance the power to identify biomarkers
for complex diseases and traits and facilitate the develop-
ment of precision medicine.
In this work, we propose harnessing eQTLs and tissue-
tissue expression-level correlations for imputing ex-
pression data in uncollected or inaccessible tissues. We
propose algorithms for multi-tissue imputation based on
a mixed-effects model12 that treats the expression mea-
sures from multiple tissues as the outcome and
considers as predictors the eQTL genotypes, known
covariates, and the estimated tissue-specific top principal
components (PCs) of expression data. By borrowing
information across genes and across related tissues, the
proposed method captures not only the genetic factors
influencing gene expression in tissues but also the major698 The American Journal of Human Genetics 98, 697–708, April 7, 2developmental and environmental factors. We conducted
simulation studies to show the superior imputation
performance of the proposed methods over existing
imputation approaches13–19 in multi-tissue expression
imputation, as well as the utility of the imputed multi-
tissue expression data. Moreover, on the basis of cross-
validation (CV) analyses of GTEx pilot data (accession
number dbGaP: phs000424.v4.p1), we demonstrated the
feasibility of imputing expression in uncollected GTEx tis-
sues (as shown in Figure 1A) and using GTEx data as a
reference for imputing expression in inaccessible tissues
from samples beyond GTEx (Figure 1B shows an
illustration).Material and Methods
A Mixed-Effects Model for Multi-tissue Imputation
For imputation of gene-expression levels in uncollected or inacces-
sible tissues, structured information—including the expression
levels of the gene of interest in observed tissues, cis- (local) and
trans- (distal) eQTLs, and sample characteristics (gender, age,
etc.) shared across genes—is uniquely available in the GTEx
data. In GTEx data, we measured the expression levels in multiple
tissues from each individual, and the multi-tissue expression mea-
sures naturally clustered within individuals.
A natural model to account for these features is a mixed-effects
model with expression levels frommultiple tissues of a gene as the
response, eQTLs and other cross-tissue or tissue-specific covariates
as predictors, and random effects (here a random intercept) for
each individual:
yit ¼ mt þ bTt xi þ aTt ci þ gi þ eit : (Equation 1)
Here, yit is the expression level of a gene in tissue type t
ðt ¼ 1;.;TÞ of individual i ði ¼ 1;.;NÞ, mt is the tissue-specific
mean expression, xi is the genotype vector of length K in individ-
ual i for K selected eQTLs (xi is the same across tissues), bt is a
vector of length K and represents the tissue-specific eQTL effects
in tissue type t, gi is the random intercept for individual i with
gi  Nð0;DÞ, ci is the vector of covariates for individual i with
at as the corresponding coefficients in tissue type t, and eit is the
error term.
In Equation 1, the effect of each eQTL can vary across tissues.
Some eQTLs consistently regulate the expression of a gene across
multiple tissues and are considered cross-tissue eQTLs, whereas
others show eQTL effects only in certain tissue types and are
considered tissue specific.4–6,20 Even for cross-tissue eQTLs, the ef-
fect sizes bt can vary by tissue type (similar to an interaction effect
of eQTL and tissue type).
To estimate the tissue-specific eQTL effects, we need to estimate
a total of T3 K parameters in Equation 1. To reduce the number of
parameters, we further employ an adaptive weighting scheme:21,22
we regress the gene expression in tissue type t on the kth eQTL and
let the marginal eQTL effect be the adaptive weight,wkt. This strat-
egy implicitly assumes that the tissue-specific eQTL effects in
different tissues in Equation 1 are proportional to the marginal tis-
sue-specific eQTL effects. In the GTEx data, we observed empirical
evidence supporting the validity of this assumption (see Supple-
mental Data for details). The pre-specified adaptive weights in
the following model allow us to account for tissue-specific eQTL016
effects with only one parameter qk for the k
th eQTL, thereby
reducing the total number of parameters for eQTL effects from
T 3 K to K:
yit ¼ mt þ
X
k
qk,ðwktxkiÞ þ aTt ci þ gi þ eit : (Equation 2)
A Mixed-Model-Based Random-Forest Approach
To obtain the predicted values of yit with weighted genotypes and
other covariates as predictors, we propose a mixed-model-based
random-forest (MixRF) approach. Random forest is an ensemble
learning method that operates by constructing a multitude of
regression trees,23 each of which considers a subset of model pre-
dictors and a subset of samples. To learn a regression tree for a
continuous outcome on the basis of some predictors, one can
employ a recursive binary partitioning algorithm.24 At each parti-
tioning, the algorithm splits the response variable on the basis of a
binary (or dichotomized) predictor in the current node such that
the reduction in the sum of squares for values in the node is maxi-
mized. The split continues until the tree is too complex or the
number of observations in the current node is too small. A regres-
sion tree is a non-linear model that predicts the value of a target
variable. Predictions based on a single regression tree can be
unstable. By aggregating overmany regression trees, a random-for-
est approach intrinsically constitutes a multiple-imputation
scheme16 and provides a more robust prediction that minimizes
the overall CV prediction (i.e., imputation) errors.23–25
Most existing random-forest approaches26,27 ignore the clus-
tered data structure. With the proposed MixRF algorithm, we
obtain the predictive values by using the following steps: for
each gene, we obtain the externally defined eQTLs or select the
eQTLs on the basis of the current data and assign the adaptive
weight to each eQTL genotype in each tissue type. We set the
initial values of g
ð0Þ
i ¼ 0. Given the estimated random effects at
the jth iteration, we build a random forest with u
ðjÞ
it ¼ yit  bgðjÞi as
the response and with weighted genotypes in each tissue
type and other covariates as predictors, u
ðjÞ
it ¼ f ðw1t x1i;.;
wKtxKi; ciÞ þ dit , where dit is the error term.We obtain the predicted
value buðjÞit . In re-estimating the random effects, we let
u
ðjÞ
it ¼ yit  buðjÞit and fit a linear random-effect model with
u
ðjÞ
it ¼ gðjÞi þ eit to obtain the estimated random effect bgðjÞi . The pro-
posedMixRF algorithm iterates through estimating the random ef-
fect gi in the linear mixed-effects model
12 and constructing a
random forest26 for the new response variable uit until the change
in the likelihood at successive iterations is small (< 0.001). The
proposed MixRF often converges quickly in a few iterations, and
the prediction is not sensitive to the specified initial values. We
summarize MixRF in algorithm 1 in Appendix A.
Our random-forest-based prediction model is a non-linear
function of the predictors in Equation 2: byit ¼ bf ðw1t x1i;.;
wKtxKi; ciÞ þ bgi: It can automatically capture the potential non-
linear effects of the predictors and the interaction effects among
the predictors on the outcome. In the multi-tissue expression
GTEx data, we observed that the eQTL effects on gene expression
levels could be additive, dominant, or recessive (such that 58%,
38%, or 4% of the eQTL expression pairs better fit an additive,
dominant, or recessive eQTL model, respectively).
In addition, we also observed eQTL-eQTL interaction effects and
gender-specific eQTLs (gender-eQTL interactions)28 on many
genes. The proposed random-forest-based predictionmodel wouldThe Ambe helpful in capturing those effects and would improve the impu-
tation performance. Moreover, because the random-forest-based
prediction model allows higher-order interactions among the pre-
dictors, it is more flexible than Lasso-type penalized regression-
based predictions and would not induce biased prediction.29An Extension to Capture the Effects of Major
Developmental and Environmental Factors in the
Imputation
We further propose an extension—MixRFþ iPC, where iPC stands
for PCs constructed from imputed and observed expression data.
Specifically, we propose (1) imputing selected gene-expression
levels with multiple eQTLs (~1,000 genes with at least three
eQTLs) by using MixRF with adaptively weighted genotypes and
other known covariates as predictors, (2) constructing tissue-spe-
cific PCs by performing singular value decomposition (SVD) on
the combined observed and imputed expression data on the
selected genes within each tissue type and keeping the top five
PCs for each tissue type, and (3) incorporating the tissue-specific
PCs with adaptively weighted genotypes and other known covari-
ates as predictors in MixRF þ iPC for imputing or re-imputing
gene-expression levels in the genome.
Most of the differences in gene expression among tissues and
many of the correlations in gene expression across tissues are
driven by the sets of genes that are not expressed in many of the
same tissues but rather are expressed in other tissues. Their expres-
sion levels are so correlated across tissues not because of shared ge-
netic architecture but because they are completely and invariantly
not expressed in so many of the same tissues. Human develop-
mental profiles are invariantly shared within our species, and
major developmental information is important information that
augments the genetic information. By borrowing information
across genes, the top PCs within each tissue type partially capture
major developmental factors, as well as the tissue-specific effects of
major environmental factors. By incorporating the top PCs from
each tissue type as predictors, the extension MixRF þ iPC im-
proves the multi-tissue imputation for genes with no eQTLs or
low heritability. We summarize MixRF þ iPC in algorithm 2 in
Appendix A.
In addition to predicting values ofmulti-tissue expression levels,
MixRF and MixRF þ iPC provide a measure of imputation qual-
ity—the estimated imputation correlation ðbr impÞ. It is estimated
on the basis of a 10-fold CV analysis of the currently observed
data. One splits the data into ten subsamples and each time uses
nine subsamples as training data and the rest as testing data.
One then applies MixRF to the training data to impute the testing
data and repeats this until all the data have been imputed once. In
the end, one calculates the correlation between the observed
expression levels and the imputed expression levels for each gene.
On the basis of simulation studies, we suggest excluding the
imputed expression levels for geneswith estimated imputationcor-
relations less than 0.3 in the subsequent analyses, although there is
nouniversal cutoff value for post-imputation exclusionor filtering.
The appropriate threshold for a specific analysis might differ.
With parallel computing, imputing 10,000 genes in nine tissue
types from about 150 individuals and obtaining the 10-fold CV-
based measures of imputation quality could be completed within
30 hr with a 40-node cluster (3.0 GHz Intel Xeon E7 processor) and
16.5 GB of memory.
The overall computation time of MixRF and MixRF þ iPC in-
creases linearly with the number of genes and the number oferican Journal of Human Genetics 98, 697–708, April 7, 2016 699
eQTLs and other covariates. The computation complexity of
random-forest-based approaches is also dependent on the total
number of observed tissues, NT, a summation of the observed tis-
sues for all individuals. The runtime of MixRF and MixRF þ iPC
scales with a complexity ofOðNT log NT Þ in the total number of tis-
sues.30 The computation is highly parallelizable.Selecting eQTLs
To obtain the eQTLs for each gene, one can use the reported eQTL
lists from other independent data. However, most of the published
eQTLs are mapped in whole blood or lymphoblastoid cell lines
and might not show eQTL effects in other tissues. In our CV ana-
lyses, we did not use the eQTLs reported in the GTEx project.9,11
Those eQTLs were calculated on the basis of all of GTEx tissues,
whereas in each round of our CVanalyses, we treated a certain pro-
portion of GTEx tissues as ‘‘uncollected,’’ imputed the expression
in those tissues, and evaluated the imputation performance. Using
eQTLs that were calculated on the basis of all tissues to impute the
expression in the ‘‘uncollected’’ tissues would have overestimated
the imputation performance.
We propose selecting eQTLs for each gene on the basis of the
observed data (for example, the training data in the CV analysis).
The selection of eQTLs might affect the predictors used in the
imputation and therefore the imputation performance. Neverthe-
less, the selection can be viewed as a pre-screening of predictors
before imputation, and this step will not lead to biased imputation
assessment yet will greatly reduce the computational burden.
When using GTEx data as a reference for imputing expression in
the uncollected tissues from other studies, one can combine the
GTEx data with data from non-GTEx samples to obtain the eQTLs
used in the imputation.
In each round of CV in our data analyses, we calculated and
selected eQTLs on the basis of only the ‘‘observed’’ (i.e., training)
data. Given the limited sample size in the GTEx pilot project, we
selected only the cross-tissue cis- and trans-eQTLs and ignored
the tissue-specific ones because of low power to detect the latter.
Most of the cis-eQTLs are cross-tissue4–6 and can potentially be
replicated in different cell contexts or even across ethnicities.31,32
To obtain the cross-tissue cis-eQTLs, we used MatrixEQTL33 to
calculate the tissue-specific cis-eQTL effects, used Stouffer’s
method34 to combine the Z statistics from the nine tissue types,
and selected the cis-eQTLs with Stouffer’s p values < 106. For
trans-eQTLs, we selected the trans-eQTLs with tissue-specific p
values % 0.05 in at least eight out of nine tissues. These selected
cross-tissue trans-eQTLs have Stouffer’s p values of less than 108.
The omission of tissue-specific trans-eQTLs in our analysis might
have hurt the imputation performance, but this can be improved
with the later phase of GTEx data, in which the project will scale
up donor collection to 900, and all 44 tissue types will have reason-
ably large sample sizes.Ethics Statements
All individuals who donated adipose and muscle biopsies in the
IS-MA (insulin-sensitivity muscle-adipose) study35 provided writ-
ten informed consent under protocols originally approved by
the institutional review board (IRB) at the University of Arkansas
for Medical Sciences.
The GTEx project involves recruitment, IRB approval, and con-
sent issues for deceased donors and their families. The collection
of tissues from deceased donors is not legally classified as human
subjects research under 45 CFR 46 in the Code of Federal Regula-700 The American Journal of Human Genetics 98, 697–708, April 7, 2tions; nevertheless, sites were required to obtain written or re-
corded verbal authorization from the next-of-kin for deceased
donor participation in GTEx.
Processing GTEx Data
Our analyses of GTEx data focused on the expression data from
nine tissue types each with R80 collected samples. We restricted
the analyses to the 150 samples with at least four observed tissues,
such that in each subsample of the CV data, each individual had
at least two observed tissues.
We applied standard data pre-processing and quality-control
procedures to both DNA and RNA sequencing data.We considered
only the 10,919 genes that were expressed in all nine tissues with a
tissue-specific log2 (mean expression level) significantly greater
(according to a one-sided t test) than the log2 of five read counts.
We normalized each gene expression in each tissue and removed
the batch effects. For genotype data, we excluded the single-nucle-
otide variants (SNVs) withminor allele frequencies less than 5% or
with p values of Hardy-Weinberg equilibrium test % 0.001 and
used PLINK36 to prune the SNVs with a linkage-disequilibrium
(LD) threshold of 0.5. After filtering and pruning, we considered
282,295 variants as potential eQTLs in the imputation analyses.Results
Simulations: Methods Comparison on Imputation
Performance
In order to evaluate the imputation performance of our pro-
posedmethods and other competing imputationmethods,
we simulated gene-expression data for 150 individuals and
nine tissue types on the basis of Equation 2. We simulated
the expression levels of 1,000 genes each with zero, one,
two, five, and ten eQTLs.We examined the imputation per-
formance of competing methods when the ‘‘heritability’’
(the percentage of expression variation explained by ge-
netic factors, here the eQTLs) ranged from 0% to 80%, a
wide range commonly observed in eQTL studies.20 We
simulated the random intercept gi  Nð0;1:262Þ and the
error term eit  Nð0; 32Þ. Given the SDs of gi and eit , the
intra-class correlation was 0.15. Additionally, we simulated
two cross-tissue covariate ci values with various effects on
the simulated gene-expression levels. The input parameters
for the simulations, including eQTL count, eQTL effect
sizes, tissue-tissue expression-level correlations, and covar-
iate effect sizes, reflected what we observed in the real data
from the GTEx pilot project.
We randomly treated 30% of all tissues as ‘‘uncollected’’
and set their gene-expression data as ‘‘missing.’’ We applied
eight imputation methods to the simulated dataset to
impute the missing gene-expression data. Those eight
competing methods were k-NN,17 missForest,16 MICE,37
linear regression (lm), liner mixed-effects model (lmer),12
REEMtree,25 MixRF, and MixRF þ iPC. The true eQTLs
wereused aspredictors in thefive regression-basedmethods,
lm, lmer,12 REEMtree,25 MixRF, and MixRF þ iPC. The me-
dian of gene-level true imputation correlations of the
1,000 genes was used for evaluating the imputation perfor-
mance. Note that here, the gene-level true imputation016
A B
Figure 2. Methods Comparison of Imputation Performance Based on Simulations
Competing methods included k-NN, missForest, MICE, lm, lmer, REEMtree, MixRF, and MixRF þ iPC.
(A) We simulated the expression levels of 1,000 genes each with zero, one, two, five, and ten eQTLs.
(B) Each expression level was simulated to be affected by two eQTLs and their interaction.
We simulated 1,000 gene-expression levels each for five varying heritability levels. We used the median of gene-level true imputation
correlations of the 1,000 genes to evaluate imputation performance. The difference between the median imputation correlations of
MixRF and those of the best alternative approach was highly significant in all scenarios (p < 2e16).correlation was calculated as the Spearman’s correlation
between the true and imputed values of a given gene in a
specific tissue type. A true correlation is distinct from the
estimated imputation correlation based on CV, br imp.
As shown in Figure 2A, our proposed methods MixRF
and MixRF þ iPC outperformed other imputation
methods, and MixRF þ iPC showed an advantage over
MixRF for imputing gene expression with zero eQTLs.
The five regression-based methods incorporated eQTL ef-
fects and performed better than other methods. The impu-
tationmethods k-NN, missForest, andMICE were designed
for single-tissue imputation—whereby selected gene-
expression levels are used for imputing the rest of the
expression levels from the same tissues—and performed
less competitively in the multi-tissue imputation.
In Figure 2B, we simulated another setting, in which
each expression level was affected by two eQTLs and an
interaction effect between them (a gene-gene interaction
effect). In this setting, we simulated 1,000 gene-expression
levels each for five varying ‘‘heritability’’ levels from 15%
to 87%. Our proposed methods MixRF and MixRF þ iPC
showed more obvious advantages over other competing
methods when the heritability was low. The likely reasons
for the observed advantages are that our methods are based
on random-forest approaches and are thus capable of
capturing the non-linear effects of predictors and their in-
teractions with minor extra computation burdens.
Simulations: Incorporating Imputed Data to Improve
the Power to Detect Phenotype-Expression
Correlations
When directly collecting certain tissues in a specific cohort
is challenging and when resources are available, one canThe Amimpute expression data on inaccessible tissues by using
available information and potentially GTEx as a reference.
We argue that the imputed data can be treated as supple-
mental data or supporting data to enhance the primary
analysis on the basis of the observed expression data. To
support this claim, we took the expression data on whole
blood, adipose tissue, and nerve tissue and the genotype
data in the GTEx pilot project and then simulated pheno-
types that were correlated (at 0.25 and 0.3) with gene-
expression levels in the nerve tissues. We treated 50% of
the nerve tissues as ‘‘uncollected’’ and set the expression
levels in those tissues as missing.
By applying the proposed MixRF þ iPC method to the
10,919 genes in the observed data (with blood, adipose tis-
sue, and 50% nerve tissue) and estimating the imputation
correlation for each gene, we obtained 1,537, 762, and 324
genes with estimated imputation correlations ðbr impÞ
greater than 0.3, 0.4, and 0.5, respectively. At the signifi-
cance thresholds of 5% and 10% false-discovery rates
(FDRs), we compared the power to detect the phenotypes
associated with the nerve expression levels on the basis
of (1) only the observed nerve expression data (50% of
the complete nerve data), (2) the combined observed and
imputed nerve expression data with varying imputation
quality (br impR 0.3, 0.4, and 0.5), and (3) the complete
GTEx nerve expression data with 95 samples.
The results are presented in Table 1. Incorporating
reasonably imputed data helped to improve the power to
detect phenotype-expression correlations even when the
phenotype-expression correlations were not strong and/
or when the quality of the imputed data was not superb.
As the imputation quality improved, the power improve-
ment became more substantial. Analyses based on poorlyerican Journal of Human Genetics 98, 697–708, April 7, 2016 701
Table 1. Power Comparison for Detecting Phenotype-Expression Correlations on the Basis of the Observed, Observed and Imputed, and
Complete Expression Data









Imputed Data Complete Data
1,537 genes ðbr impR0:3Þ 0.25 0.05 0.269 0.377 0.953
0.1 0.455 0.586 1
0.3 0.05 0.548 0.738 1
0.1 0.729 0.898 1
762 genes ðbr impR0:4Þ 0.25 0.05 0.230 0.652 0.933
0.1 0.391 0.839 1
0.3 0.05 0.613 0.734 1
0.1 0.778 0.887 1
324 genes ðbr impR0:5Þ 0.25 0.05 0.454 0.534 1
0.1 0.688 0.744 1
0.3 0.05 0.676 0.784 1
0.1 0.883 0.926 1
More specifically, the three sources of expression data were (1) only the observed nerve expression data (from which 50% of GTEx nerve tissue was missing),
(2) the observed and imputed data with varying imputation quality, and (3) the complete GTEx nerve expression data. The significance thresholds were 5%
and 10% FDRs. We assessed the power comparison when the phenotype-expression correlations were 0.25 and 0.3 for three groups of genes with estimated
imputation correlations of at least 0.3, 0.4, and 0.5 (representing fair, moderate, and good imputation quality, respectively).imputed genes might not help or might even hurt the po-
wer of the analyses. Although only a small proportion of
imputed gene-expression levels might be retained in the
subsequent analyses after exclusion of the poorly imputed
expression levels, those genes are often affected by multi-
ple eQTLs and/or related to other factors in functional
pathways and, as such, are often of biological interest.
Analyses of GTEx Data: Imputing Uncollected GTEx
Tissues
The GTEx project is collecting 44 human tissue types, and
most of them are difficult to access. In the pilot data, only
nine tissue types were collected in more than 80 out of
175 donors, and the remainder yielded tissue-specific sam-
ple sizes of less than 40. We sought to impute the uncol-
lected GTEx tissues by using MixRF þ iPC (Figure 1A). We
conducted a 10-fold CVanalysis focusing on the nine tissue
types to evaluate the imputation performancewithinGTEx.
Specifically, we randomly split theGTEx transcriptome data
on the nine tissue types into ten subsamples each contain-
ing data on one-tenth of the collected tissues from each tis-
sue type. In each round of CV analysis, we treated one
subsample of the transcriptome data as unobserved and un-
collected and the other nine subsamples as observed or
collected. For eachgene,we imputed theunobservedexpres-
sion levels in uncollected GTEx tissues by using the expres-
sion levels in the collected tissues (the imputation scheme is
illustrated in Figure 1A). We repeated the exercise for each
subsample of data, combined the imputed data, and evalu-
ated the true tissue-specific imputation correlations.
The imputation performance of MixRF was generally
comparable with that of its extension, MixRF þ iPC,702 The American Journal of Human Genetics 98, 697–708, April 7, 2although the latter performed better in imputing gene
expression with no eQTLs or in the blood tissue (Table
S1). We also compared the true imputation correlations
from MixRF þ iPC with the standard practice of using
blood expression as a surrogate for target-tissue expression
(hereafter referred to as ‘‘blood surrogate’’) (Figure 3). The
imputation performance of MixRF þ iPC largely relied on
the heritability and tissue-tissue expression-level correla-
tions for each gene, both of which were directly related
to the number of cross-tissue eQTLs. For genes with five
or more combined cis- and trans-eQTLs, the median true
imputation correlation was 0.48. For genes with 10þ and
30þ eQTLs, the median true imputation correlation
increased to 0.55 and 0.63, respectively. Note that
although we used PLINK36 to perform LD pruning (with
a LD threshold of 0.5 and a window size of 50 bp) on the
SNVs, moderate LD could still remain among the eQTLs.
Among the 10,919 expressed genes that we considered,
the genes with 5þ, 10þ, and 30þ eQTLs in at least one sub-
sample of the CV data numbered 1,065 (9.8%), 465 (4.3%),
and 170 (1.6%), respectively.
Generally, expression in whole blood is weakly corre-
lated (with a median correlation of 0.1) with expression
in other tissues and is a poor surrogate for the latter. We
compared the imputation performance of the proposed
methods with that of additional competing imputation
methods for genes with different numbers of eQTLs (Table
S1). Additionally, we evaluated the sample-level true impu-
tation correlations (Figure S1), whichwere calculated as the
correlations between the observed and imputed gene ranks
for each sample in each tissue. The imputed gene ranks
could be useful in analyses of gene-set enrichment.38016
Figure 3. Boxplots of Gene-Level True Imputation Correlation by Tissue Type
The results are based on a 10-fold CV analysis within GTEx tissues. Specifically, we randomly split the GTEx transcriptome data into ten
subsamples, each of which contained one-tenth of the collected tissues from each tissue type. In each round of CV analysis, we treated
one subsample of the transcriptome data as unobserved and the other nine subsamples as observed. We then imputed the unobserved
data. Figure 1A illustrates the imputation scheme in one round of the CV analysis. We repeated the analysis for each subsample of data.
Each correlation was calculated as the Spearman’s correlation between the observed and combined imputed values of a given gene in the
current tissue. We compared the true imputation correlations based on MixRF þ iPC for genes with zero, at least five, and at least ten
eQTLs with the correlations based on blood surrogate. Note that the eQTLs for each gene can be in moderate LD.To evaluate the impact of sample size on imputation,
we performed a 3-fold CV analysis within GTEx tissues
and compared the results with those obtained from the
10-fold CV analysis (Table 2). In each round of the 3-fold
and 10-fold CV analyses, two out of three and nine
out of ten data subsamples, respectively, were treated as
‘‘observed,’’ yielding average tissue-specific sample sizes
of 73 and 99, respectively. We found that sample size sub-
stantially affected imputation performance largely because
sample size substantially affected the power to detect
cross-tissue eQTLs. With a 36% sample-size increase in
the 10-fold CV analysis and the same significance criteria,
we detected 65% more cross-tissue cis-eQTLs (8,792 versus
5,332) and 225% more cross-tissue trans-eQTLs (12,884
versus 3,976). As a result, the median true imputation
correlation across the genome improved from 0.305 to
0.349. Additional simulations are presented in the Supple-
mental Data to further demonstrate the impact of sample
size on imputation. When more GTEx samples become
available, we expect further improvement in imputation
performance.
Overall, both eQTL and tissue-tissue expression-level
correlations play a major role in multi-tissue imputation.
The average estimated heritability for expressed genes was
reported to be 0.14 ~ 0.26 for different tissue types in other
studies,39,40 which roughly corresponds to an imputation
correlation of 0.37 ~ 0.51 if the appropriate SNVs were
selected in the imputation.According toour results, theme-
dian true imputation correlationbasedon linear regressions
that use only eQTLs as predictors (see ‘‘lm’’ in Table S1) was
much lower (~0.2), indicating that the current imputationThe Amresults could be improved if sample size were to increase
andmore eQTLs were detected and used in the imputation.
Additional comparison of linear-regression and mixed-
effects models (Table S1) showed that information on tis-
sue-tissue expression-level correlation helped improve the
absolute median imputation correlation by 0.1 ~ 0.3 for
genes with at least five or at least ten eQTLs. For genes
with no eQTLs, the median imputation correlation with
mixed-effects models was nearly 0.3 and was higher than
that from using blood expression as a surrogate.
Analyses of GTEx Data: Using GTEx as a Reference to
Impute Other Studies
Tissue accessibility often limits the feasibility and scale of
multi-tissue expression studies in specific cohorts. Multi-
tissue expression imputation would be helpful when direct
measurements in specific tissues are limited or not avail-
able and when expression data on related tissues are exist-
ing or accessible. Incorporating expression in secondary
and related tissue types into the primary data might
enhance the power to detect differentially expressed genes
under different phenotypic conditions and provide in-
sights into disease etiology from a multi-tissue perspective.
Multi-tissue imputation could impute expression in the
uncollected tissues, which could be used as supplemental
data to be combined with the primary observed data in
the secondary data analysis. In those imputation scenarios,
one can use GTEx as a reference and impute gene expres-
sion in the uncollected tissues or tissue types in non-
GTEx samples. Figure 1B shows an example of such
imputation scenarios.erican Journal of Human Genetics 98, 697–708, April 7, 2016 703
Table 2. Comparing 10-fold and 3-fold CV Analyses within GTEx Tissues Shows the Impact of Sample Size
10-fold CV Analysis 3-fold CV Analysis
Average sample size across tissues 98.9 73.2
Average no. of cis-eQTLs 8,792 5,332
Average no. of trans-eQTLs 12,884 3,976
















No. of Genes with
True Imputation
Correlation R 0.5 (%)
Genes with no eQTLs 9,240 0.307 207 (2.2) 10,063 0.271 88 (0.9)
Genes with one eQTL 5,062 0.338 250 (4.9) 2,521 0.317 62 (2.5)
Genes with two eQTLs 2,486 0.368 228 (9.2) 767 0.355 63 (8.2)
Genes with three eQTLs 1,394 0.386 191 (13.7) 371 0.390 44 (11.9)
Genes with four eQTLs 883 0.412 169 (19.1) 225 0.401 48 (21.3)
Genes with five to nine eQTLs 839 0.430 191 (22.8) 275 0.454 90 (32.7)
Genes with at least ten eQTLs 465 0.521 270 (58.1) 185 0.578 128 (69.2)
Increasing the sample size affected the power to detect cross-tissue eQTLs and thus imputation results. The number of genes with x eQTLs is counted as the
number of genes with x eQTLs in at least one subsample of the CV data. For example, genes might have no eQTLs in one or several subsamples of the CV
data and have one or two eQTLs in other subsamples of the CV data. We calculated the true imputation correlation for genes with no eQTLs by only considering
the subsamples of the CV data in which the gene had no eQTLs. As such, there was overlap among genes with zero, one, or two eQTLs, etc.We conducted another 10-fold CV analysis to evaluate
the feasibility of such imputation. Unlike in the 10-fold
CVanalysis conducted in the previous section, herewe split
theGTEx individuals into ten subsamples. In each round of
the current CV analysis, we treated nine subsamples of the
GTEx individuals as the ‘‘GTEx reference’’ and the other
subsample as testing samples from a new study. In the
new samples, we only observed the transcriptome data in
the three accessible tissues and used the data on the three
tissues with GTEx as a reference to impute the expression
in the uncollected tissues in the new samples (Figure 1B).
We used MixRF þ iPC to evaluate the tissue-specific
gene-level true imputation correlations in the six inacces-
sible tissue types (Figure 4). Blood surrogate achieved a me-
dian correlation of only ~0.1. In contrast, even for genes
with no eQTLs, MixRFþ iPC achieved amedian true impu-
tation correlation of 0.17–0.27 in different tissue types. For
genes with at least ten eQTLs, the median true imputation
correlation increased to ~0.4 across tissue types. The impu-
tation performance was better in nerve tissue than in other
tissues in that it achieved a median correlation of 0.37,
0.42, and 0.54 for genes with 5þ, 10þ, and 30þ eQTLs,
respectively. This might be attributable to the relatedness
between nerve tissue and adipose tissue and skin or to its
reaction to stimuli. We also assessed the sample-level true
imputation correlations (Figure S2), and the conclusions
were similar.
Additionally, one can also use multi-tissue imputation to
build on existing single-tissue expression and eQTL data.
One can collect the tissues of interest in a small set of
new samples in the specific cohorts as the learning tissues704 The American Journal of Human Genetics 98, 697–708, April 7, 2and then use those tissues together with the GTEx refer-
ence samples to impute the samples with expression data
only on a single tissue and not available for additional
data collection.
The multi-tissue imputation strategy can also be used in
designing future multi-tissue expression studies in certain
populations or ethnicities or with specific phenotypes.
One can utilize the GTEx resource and conduct CV ana-
lyses on the GTEx tissues. By leveraging tissue availability
and predictability, one can select the tissue types that are
most relevant and predictive for the target tissue types.
Using GTEx as a Reference in the Presence of Potential
Study Heterogeneity and a Validation Analysis
The performance of the proposed multi-tissue imputation
methods primarily depends on the predictive ability of
eQTLs and the tissue-tissue expression-level correlations.
We suggest including a reference-sample indicator variable
in the MixRF as a covariate when using GTEx as a reference
for imputing other non-GTEx samples with potential
study heterogeneity. When the eQTL effects or effects of
other covariates are sufficiently different among the
GTEx reference and the non-GTEx samples, the interaction
terms of the reference indicator and the eQTLs or other
covariates will be selected in building the random forest.
As such, in the presence of study heterogeneity, the estima-
tion of eQTL effects in the non-GTEx samples will be based
primarily on the non-GTEx samples only.
Recent studies have shown that the predictive ability of
eQTLs can be replicated across GTEx and other studies,20
and the expression patterns of many pharmacogenes016
Figure 4. Boxplots of Gene-Level True Imputation Correlation in Inaccessible Tissues in a New Study
The results are based on a 10-fold CV analysis of imputing uncollected tissues in the new samples while using GTEx as a reference.
Specifically, we split the GTEx individuals into ten subsamples. In each round of CV analysis, we used nine subsamples as a reference
and treated the other subsample as new. With GTEx data as a reference, we imputed the transcriptome data in the inaccessible tissues
on the basis of the accessible ones (blood, skin, and adipose) in the new samples. Figure 1B illustrates the imputation scheme in one
round of CV analysis. We repeated the analysis for each subsample of data. We compared the true imputation correlations based on
MixRF þ iPC for genes with zero, at least five, and at least ten eQTLs with the correlations based on blood surrogate.investigated by the Pharmacogenomics Research Network
project can also be validated in the GTEx samples.41
To further validate the utility of the proposed methods
and of GTEx data as a reference in multi-tissue imputation
for non-GTEx samples, we applied MixRF to the IS-MA
study on insulin (INS [MIM: 176730]) sensitivity (accession
number GEO: GSE40234).35 Fifty-nine samples at the tails
of the distribution of insulin sensitivity were selected in
the study. The expression levels on adipose and muscle tis-
sues and genotype data are available on those 59 samples.
We considered 229 genes with preserved Ensembl IDs in
both GTEx and the IS-MA study. Such genes are likely to
have completely preserved gene structure across the two
datasets. We normalized the expression levels of each
gene within each study. We focused on imputing the
expression levels of those 229 genes in the muscle tissues
from the IS-MA samples.
We compared the performance of the following analyses
to impute the muscle-tissue expression levels in the IS-MA
samples: (1) imputing with GTEx reference and adipose
expression levels and eQTLs from the IS-MA study; (2)
imputing with GTEx reference and adipose expression
levels from the IS-MA study, but not eQTLs; and (3)
imputing on the basis of the eQTLs, but not GTEx as a refer-
ence, from the IS-MA study. We calculated the imputation
correlations of measured muscle-tissue expression levels
and the imputed values on the basis of the three sets of an-
alyses. Figure S3 shows the quantile-quantile plot of the
three sets of imputation correlations against the null corre-
lations. Including GTEx as a reference greatly improved the
imputation performance, and the mean imputation corre-
lation of those 229 genes according to analysis 1 wasThe Am0.313. When imputation was based only on tissue-tissue
expression-level correlations (analysis 2) or eQTLgenotypes
(analysis 3), the imputation correlations substantially
deviated from the null correlations. This implies that both
tissue-tissue expression-level correlations and eQTL geno-
types help in multi-tissue imputation. MixRF with GTEx
as a reference combines the two sources of information
and improves the overall imputation.Discussion
The joint analysis of transcriptome data from multiple
tissues would enhance the power of analyzing expres-
sion data and ultimately improve our understanding of
biological mechanisms from a systems perspective. The
bottleneck that limits the feasibility and scale of studies
of multi-tissue expression is tissue accessibility. When a
tissue is not accessible in an individual, the gene-expres-
sion levels in that tissue are not available and are con-
sidered ‘‘missing.’’ We propose algorithms for imputing
multi-tissue expression data. The proposed approaches
can be used for imputing expression on uncollected tissues
in the GTEx project to facilitate downstream analyses and,
moreover, for imputing inaccessible tissues in other
expression studies while using GTEx as a reference.
Different from methods that predict expression levels on
the basis of eQTL information,20 our proposed methods
impute multi-tissue expression levels on the basis of
eQTLs, tissue-tissue expression-level correlations, and
tissue-specific PCs of expression data and harness genetic
factors, major developmental biological factors, anderican Journal of Human Genetics 98, 697–708, April 7, 2016 705
environmental factors. Additionally, our MixRF approach
captures the dominant and recessive eQTL effects, as well
as the interactions among eQTLs, tissue types, and other
factors. Most existing single-tissue imputation methods
rely on gene-gene correlations, which can be unstable.
Our methods outperform existing imputation methods in
multi-tissue imputation.
Multi-tissue imputation can be helpful when direct mea-
surements in the desired tissues are uncollected or difficult
to collect, and one can use the imputed data as supplement
data to support scientific findings from observed data.
Within the GTEx project, we can impute the expression
in the uncollected tissues and use imputed expression
data to enhance the detection of protein QTLs or facilitate
the construction of integrative genomics networks. More
importantly, by using GTEx as a reference, we can poten-
tially impute inaccessible tissues inother expression studies,
impute and recapitalize on existing data, design effective
multi-tissue expression studies in other populations or eth-
nicities, and further informdisease-related tissues.We antic-
ipate that our multi-tissue imputation method will initiate
researchonmethodsdevelopment andenable thediscovery
of scientific findings with the use of multi-tissue expression
data within and beyond the GTEx project.
One caveat of the current analyses is that we used only
cross-tissue eQTLs in the imputation. The sample size in
the GTEx pilot data limits the power to detect tissue-spe-
cific eQTLs. We believe that a larger sample size in the later
phase of GTEx data will bring increased power to detect
both cross-tissue and tissue-specific eQTLs and thereby
substantially improve imputation performance. An alter-
native strategy for selecting eQTLs is to combine the eQTLs
reported in other studies, which ideally involve multiple
tissue types.
We anticipate that the later phase of GTEx data will
bring additional challenges to methods development,
e.g., the scalability of the approaches and the selection of
the accessible tissues for maximizing imputation accuracy.
In addition to enabling multi-tissue imputation, it is desir-
able to develop methods that account for observed and
imputed expression values in the subsequent disease- or
trait-related analyses and to enable multi-tissue network
and integrative analyses.Appendix A
Algorithm 1: MixRF, a Mixed-Model-Based Random-
Forest Approach for Imputing Multi-tissue Expression
1. For each gene, use externally defined eQTLs or select
eQTLs on the basis of the currently observed data.
Obtain the adaptive weights (wkt) for each eQTL in
each tissue type.
2. Initialize the random-effects estimate in Equation 2,
bgð0Þi ¼ 0.
3. At the jth iteration, let u
ðjÞ
it ¼ yit  bgðj1Þi . Build a
random forest with u
ðjÞ
it as the response and weighted706 The American Journal of Human Genetics 98, 697–708, April 7, 2genotypes in each tissue and other covariates (ci) as
predictors, u
ðjÞ
it ¼ f ðw1tx1i;.;wKtxKi; ciÞ þ dit : Obtain
the predicted value buðjÞit .
4. Let u
ðjÞ
it ¼ yit  buðjÞit . Fit a linear random-effects-only
model with u
ðjÞ
it as the response, u
ðjÞ
it ¼ gðjÞi þ eit :
Obtain the estimated random effect bgðjÞi .
5. Iterate through steps 3 and 4 until the change in the
likelihood is small.
Algorithm 2: MixRF þ iPC, a MixRF Extension
Incorporating PCs of Expression Data
0. Select eQTLs.
1. For each tissue type, construct the top PCs of com-
bined observed and imputed expression data on
selected genes to capture unknown sample charac-
teristics and tissue-specific major developmental
patterns and environmental effects.01i. Impute the selected gene-expression levels (here,
we imputed the expression levels of ~1,000 genes
with at least three eQTLs) by using MixRF with
adaptively weighted eQTL genotypes and other
known covariates as predictors.
ii. For each tissue type, perform SVD on the com-
bined observed and imputed data on the selected
genes, and keep the top five PCs. (Note that the
results based on the top ten PCs are similar.)
2. Apply MixRF to each gene by using gene expression
as the response and using adaptively weighted eQTL
genotypes, other known covariates, and the con-
structed tissue-specific PCs from step 1 as predictors.Acknowledgments
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